Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

The conversation is about selling KY19382 powder, a novel activator of Wnt/β-catenin signaling, and Kolliphor EL liquid for vehicle formulation. The seller offers worldwide shipping.

Pelage is moving to Phase III clinical trials for PP405, a hair loss treatment, with results to be presented at a medical meeting. Users express skepticism and hope, comparing it to existing treatments like Minoxidil and finasteride, while discussing the potential for new hair growth in previously bald areas.

ET-02, a PAI-1 inhibitor, is not proven to be more effective than Minoxidil for hair loss. Other treatments like finasteride, dutasteride, PP405, and AMP-303 are also discussed, focusing on cellular senescence and oxidative stress.

Minoxidil can be effectively delivered through nanoemulsions containing eucalyptol or oleic acid, enhancing its diffusivity and targeting hair follicles. This contradicts the advice against mixing minoxidil with oils in topical formulations.

A 23-year-old has been using 5% minoxidil and derma stamping for three months to address hair loss, with noticeable improvement. Users suggest adding finasteride to prevent further hair loss, as minoxidil alone doesn't address the underlying DHT issue.

The user has been using finasteride and minoxidil for 11 months but experienced hair thinning after adding topical dutasteride. They plan to continue with Lipogaine, finasteride, and a reduced frequency of topical dutasteride, along with dermarolling and biotin.

P-1075 is a more potent hair growth agent than Minoxidil, but it poses significant heart risks, making it unsafe for use. Despite promising results in macaques, concerns about its cardiotoxicity in rats have halted its development.

A user shared progress pictures after 4 months of using oral Minoxidil and Finasteride, noting significant hair growth and some greying. Replies praised the results and inquired about the user's age, who is 33.

The user shared six months of progress using oral finasteride (1.2mg) and minoxidil (3mg) with positive results. They do not use topical minoxidil and have not experienced side effects like erectile dysfunction.

PP405 is being compared to Minoxidil, with some suggesting it might be more effective since it's specifically designed for hair loss. Minoxidil was originally for blood pressure, and its hair growth effect is a side effect.

The user shared a 4-month update on their hair regrowth journey using finasteride, minoxidil, and microneedling, reporting significant progress and styling ability. They emphasized persistence, shared their regimen details, and addressed side effects like weaker erections and blurry vision, which improved with lifestyle changes.

A user is seeking a titanium dioxide-free finasteride pill due to health concerns. They have not found a suitable supplier yet.

PP405 is a new hair loss treatment advancing quickly in trials, generating excitement and skepticism about its effectiveness and marketing claims. Some see it as a potential alternative to minoxidil and finasteride, but concerns about long-term effects and the need for DHT blockers persist.

A 25-year-old male has been using Minoxidil foam for 3 years and topical Finasteride for 2 years to address hair loss, with plans to increase Finasteride concentration. He is considering additional treatments like microneedling and RU58841, while seeking advice on whether to switch back to oral Finasteride despite concerns about side effects.

User shared 16-month progress using finasteride 1 mg/day and minoxidil 5% solution once/day, noting significant regrowth, especially in temporal peaks. Users discussed shedding, side effects, and positive feedback from others.

Increasing the sult1a1 enzyme on the scalp may improve response to topical minoxidil. The user suggests using a baking soda solution, DMSO, and tretinoin to enhance enzyme activity and minoxidil effectiveness.

The user is using topical finasteride 0.3% and minoxidil 5% for hair regrowth, along with dermal stamping, zinc, fish oils, and biotin. They report some regrowth and shedding, with no significant side effects.

A user is experiencing hair loss despite using topical minoxidil for 6 months and recently switching to foam, and is considering finasteride but is wary of side effects. Another user suggests continuing treatment and considering finasteride.

The user switched from oral minoxidil to topical minoxidil and added JXL-069/PP405-3HP, along with topical dutasteride, melatonin, and tretinoin. They also use low-level laser therapy (LLLT) but doubt its effectiveness.

2% fucoidan alleviated AGA symptoms, promoted hair growth, and increased hair density in mice. Fucoidan is considered safe for humans as a supplement and topical skincare product, with potential therapeutic effects against AGA.

The conversation is about a user sharing their positive hair regrowth progress using 1mg oral finasteride and topical minoxidil. The user encourages others to try treatment early if they are unsure.

The conversation discusses the use of oral minoxidil for hair loss, with some users suggesting combining it with finasteride for better results. Opinions vary on the effectiveness of minoxidil alone, especially for younger individuals, while others emphasize the importance of finasteride in treating male pattern baldness.

The user experienced aggressive hair thinning starting in late 2023 and began using Minoxidil consistently in October 2025, along with Vitamin D supplements. After three months, they shared progress photos showing improvement in hair density.

PP405 shows initial promise for treating androgenetic alopecia, with safety confirmed in early trials, but skepticism remains due to limited data. Further trials are needed to determine its true efficacy and potential market impact.

A user shared their 3-month progress using 0.5mg daily dutasteride and 3mg oral minoxidil for hair loss, reporting significant improvement after an initial shedding phase. The user experienced no side effects and noted that dutasteride might have fewer side effects than finasteride.

The user shared their 4-month progress using oral finasteride and topical minoxidil, with a specific application routine. They adjust the minoxidil application to manage costs, applying it daily with variations in quantity and additional tretinoin on certain days.

The user saw hair improvement with minoxidil, finasteride, and a red light cap, noting better results after adding finasteride and stressing routine consistency.

The user has been using oral minoxidil and finasteride for 6 months with no regrowth and increased shedding, and recently switched to a higher dose of minoxidil. Suggestions include switching to dutasteride, adding topical anti-androgens like RU58841, and considering a hair transplant.

A 28-year-old shared impressive hair growth progress after using Minoxidil once daily for three months, with a dermaroller used only in the second month. A user complimented the results and inquired about any shedding.

Recruitment for a verteporfin trial and a separate hair cloning trial using verteporfin and other methods is underway, with locations in Jordan, NYC, Beverly Hills, and Memphis. Dr. Bloxham is conducting the hair cloning trial, and interested participants are encouraged to contact him directly.